Novartis CEO says it is watching US reciprocal tariff policy 'very carefully' [Yahoo! Finance]
Novartis AG (NVS)
Last novartis ag earnings: 4/28 01:00 am
Check Earnings Report
US:NYSE Investor Relations:
novartis.com/investors
Company Research
Source: Yahoo! Finance
States would unfold in early April, Chief Executive Vas Narasimhan said in Tokyo.U.S. President Donald Trump last month flagged potential import duties of about 25% on pharmaceuticals as part of measures affecting other industries, including semiconductors and automobiles, as he seeks to reshape global trade. Novartis plans to start mass production of radiopharmaceuticals, a type of precision cancer treatment, in Japan in 2026, the Nikkei newspaper reported earlier this month. Last year, Novartis agreed to buy U.S.-based Mariana Oncology for $1 billion upfront to expand its portfolio of the drugs, which currently include prostate cancer treatment Pluvicto and Lutathera used for a rare group of gastrointestinal tumours. (Reporting by Rocky Swift; Editing by Kim Coghill) View Comments
Show less
Read more
Impact Snapshot
Event Time:
NVS
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
NVS alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
NVS alerts
High impacting Novartis AG news events
Weekly update
A roundup of the hottest topics
NVS
News
- Olema: 'Strong Buy' Maintained On OPERA-02 Trial Initiation & Additional Shots On Goal [Seeking Alpha]Seeking Alpha
- 2 Top Stocks to Buy and Hold for the Long Term [Yahoo! Finance]Yahoo! Finance
- Nine Drugmakers Strike Deals With Trump, More Coming Next Year [Yahoo! Finance]Yahoo! Finance
- Novartis and US government reach agreement on lowering drug prices in the US [Yahoo! Finance]Yahoo! Finance
- Novartis' myasthenia gravis asset iptacopan granted FDA Orphan Drug status [Seeking Alpha]Seeking Alpha
NVS
Earnings
- 10/28/25 - Miss
NVS
Sec Filings
- 11/25/25 - Form 6-K
- 11/20/25 - Form 6-K
- 11/5/25 - Form 6-K
- NVS's page on the SEC website